EFEarnings Feed

C

Company dossier

CORIXA CORP

CIK 0001042561SIC 2836Biological Products, (No Diagnostic Substances)

Add to watchlist

Exchange

—

Entity type

operating

Fiscal year end

Dec 31

Headquarters

DE

SEC profile ↗

Recent filings

Latest submissions

10 items

10-QAccepted Nov 7, 7:00 PM ETAcc 0000891020-99-001820
CORIXA CORP117.6 KB
CORIXA CORP 10-Q
View filing
8-KAccepted Oct 20, 8:00 PM ETAcc 0000891020-99-001747
CORIXA CORP137.8 KB
CORIXA CORP 8-K
View filing
8-KAccepted Aug 17, 8:00 PM ETAcc 0000891020-99-001451
CORIXA CORP128.5 KB
CORIXA CORP 8-K
View filing
8-KAccepted Aug 8, 8:00 PM ETAcc 0000891020-99-001329
CORIXA CORP52.2 KB
CORIXA CORP 8-K
View filing
10-QAccepted Aug 8, 8:00 PM ETAcc 0000891020-99-001330
CORIXA CORP450.5 KB
CORIXA CORP 10-Q
View filing
8-KAccepted Aug 8, 8:00 PM ETAcc 0000891020-99-001328
CORIXA CORP60.2 KB
CORIXA CORP 8-K
View filing
8-KAccepted Jun 29, 8:00 PM ETAcc 0000891020-99-001114
CORIXA CORP10.1 KB
CORIXA CORP 8-K
View filing
8-KAccepted Jun 2, 8:00 PM ETAcc 0000891020-99-000956
CORIXA CORP10.2 KB
CORIXA CORP 8-K
View filing
10-QAccepted May 5, 8:00 PM ETAcc 0000891020-99-000767
CORIXA CORP146.0 KB
CORIXA CORP 10-Q
View filing
8-KAccepted Apr 22, 8:00 PM ETAcc 0000891020-99-000711
CORIXA CORP286.6 KB
CORIXA CORP 8-K
View filing

Monitoring

Insider owner filings: No
Insider issuer filings: Yes
Tickers on record: 0

Ticker roster

No tickers on record.

Addresses

business
1900 9TH AVENUE SUITE 1100
SEATTLE, WA, 98101
mailing
1900 9TH AVENUE SUITE 1100
SEATTLE, WA, 98101